Compare Stocks

Date Range: 

 Siemens Healthineers(BUX)12144BARD1 Life SciencesCharles River Laboratories International
SymbolOTCMKTS:SMMNYCNSX:BUXCNSX:IMEASX:BD1CNSX:CRL
Price Information
Current Price$29.47N/AN/AN/AN/A
52 Week RangeBuyN/AN/AN/AN/A
MarketRank™
Overall Score0.50.50.50.50.5
Analysis Score0.00.00.00.00.0
Community Score2.52.52.62.42.4
Dividend Score0.00.00.00.00.0
Ownership Score0.00.00.00.00.0
Earnings & Valuation Score0.00.00.00.00.0
Analyst Ratings
Consensus RecommendationHoldN/AN/AN/AN/A
Consensus Price TargetN/AN/AN/AN/AN/A
% Upside from Price TargetN/AN/AN/AN/AN/A
Trade Information
Market CapN/AN/AN/AN/AN/A
BetaN/AN/AN/AN/AN/A
Average Volume50,966N/AN/AN/A33,785
Sales & Book Value
Annual RevenueN/AN/AN/A$612,251.00N/A
Price / SalesN/AN/AN/A0.00N/A
CashflowN/AN/AN/AN/AN/A
Price / CashN/AN/AN/A4.33N/A
Book ValueN/AN/AN/AA$0.49 per shareN/A
Price / BookN/AN/AN/A0.00N/A
Profitability
Net IncomeN/AN/AN/AN/AN/A
EPSN/AN/AN/AA($0.08)N/A
Trailing P/E Ratio0.000.000.000.000.00
Forward P/E RatioN/AN/AN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net MarginsN/AN/AN/AN/AN/A
Return on Equity (ROE)N/AN/AN/AN/AN/A
Return on Assets (ROA)N/AN/AN/AN/AN/A
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity RatioN/AN/AN/A3.65%N/A
Current RatioN/AN/AN/A6.32%N/A
Quick RatioN/AN/AN/A5.93%N/A
Ownership Information
Institutional Ownership PercentageN/AN/AN/AN/AN/A
Insider Ownership PercentageN/AN/AN/AN/AN/A
Miscellaneous
Employees54,500N/AN/A5N/A
Shares OutstandingN/AN/AN/A80.06 millionN/A
Next Earnings DateN/AN/AN/AN/AN/A
OptionableNot OptionableNot OptionableNot OptionableNot OptionableOptionable
SourceHeadline
Charles River: Q1 Earnings InsightsCharles River: Q1 Earnings Insights
benzinga.com - May 4 at 8:38 AM
Charles River: Q1 Earnings SnapshotCharles River: Q1 Earnings Snapshot
sfgate.com - May 4 at 8:38 AM
Charles River Labs Boosts FY21 Outlook - Quick FactsCharles River Labs Boosts FY21 Outlook - Quick Facts
nasdaq.com - May 4 at 8:38 AM
Ileal transposition helps to regulate plasma hepatokine levels in obese Zucker (Crl:ZUC(ORL)-Lepr fa) ratsIleal transposition helps to regulate plasma hepatokine levels in obese Zucker (Crl:ZUC(ORL)-Lepr fa) rats
nature.com - April 9 at 11:40 PM
I Ran A Stock Scan For Earnings Growth And Charles River Laboratories International (NYSE:CRL) Passed With EaseI Ran A Stock Scan For Earnings Growth And Charles River Laboratories International (NYSE:CRL) Passed With Ease
finance.yahoo.com - April 4 at 1:00 PM
Charles River Laboratories Prices $1 Billion of Senior NotesCharles River Laboratories Prices $1 Billion of Senior Notes
finance.yahoo.com - March 9 at 9:28 AM
Charles River signs deal to get exclusive access to Kibur Medical’s implantable microdeviceCharles River signs deal to get exclusive access to Kibur Medical’s implantable microdevice
seekingalpha.com - March 8 at 11:37 PM
Charles River Laboratories International Inc (CRL) Chairman, President and CEO James C Foster ...Charles River Laboratories International Inc (CRL) Chairman, President and CEO James C Foster ...
finance.yahoo.com - February 24 at 4:02 PM
Charles River Laboratories International, Inc.: Charles River Reports Strong Q4 Results and Acquisition of Cognate BioServices; Raising FVE to $161Charles River Laboratories International, Inc.: Charles River Reports Strong Q4 Results and Acquisition of Cognate BioServices; Raising FVE to $161
finance.yahoo.com - February 19 at 6:36 PM
A Look Into Charles Rivers DebtA Look Into Charles River's Debt
finance.yahoo.com - February 18 at 12:09 PM
Charles River Laboratories (CRL) Beats Q4 Earnings and Revenue EstimatesCharles River Laboratories (CRL) Beats Q4 Earnings and Revenue Estimates
nasdaq.com - February 17 at 10:58 AM
A Preview Of Charles Rivers EarningsA Preview Of Charles River's Earnings
benzinga.com - February 16 at 12:36 PM
Estimating The Fair Value Of Charles River Laboratories International, Inc. (NYSE:CRL)Estimating The Fair Value Of Charles River Laboratories International, Inc. (NYSE:CRL)
finance.yahoo.com - January 22 at 8:10 AM
Charles River Labs Eyes SuperHuman Gains As Breakout NearsCharles River Labs Eyes 'SuperHuman' Gains As Breakout Nears
finance.yahoo.com - January 6 at 10:26 AM
Charles River Labs buys South San Francisco company in all-cash dealCharles River Labs buys South San Francisco company in all-cash deal
bizjournals.com - January 5 at 1:40 PM
Is CRL A Good Stock To Buy Now?Is CRL A Good Stock To Buy Now?
finance.yahoo.com - December 25 at 7:31 PM
If You Had Bought Charles River Laboratories International (NYSE:CRL) Stock Five Years Ago, You Could Pocket A 214% Gain TodayIf You Had Bought Charles River Laboratories International (NYSE:CRL) Stock Five Years Ago, You Could Pocket A 214% Gain Today
finance.yahoo.com - December 23 at 7:15 AM
Charles River Delivers Industry-First Deciphex Patholytix Digital Pathology Peer Review for GLP StudiesCharles River Delivers Industry-First Deciphex Patholytix Digital Pathology Peer Review for GLP Studies
finance.yahoo.com - December 9 at 9:26 AM
Charles River Laboratories International Inc CRLCharles River Laboratories International Inc CRL
morningstar.com - November 27 at 11:42 PM
Is Now An Opportune Moment To Examine Charles River Laboratories International, Inc. (NYSE:CRL)?Is Now An Opportune Moment To Examine Charles River Laboratories International, Inc. (NYSE:CRL)?
finance.yahoo.com - November 27 at 7:24 AM
Charles River Laboratories Intl, Inc. -- Moodys upgrades Charles Rivers CFR to Ba1; outlook stableCharles River Laboratories Int'l, Inc. -- Moody's upgrades Charles River's CFR to Ba1; outlook stable
finance.yahoo.com - November 20 at 7:21 PM
Have Charles River Laboratories International, Inc. (NYSE:CRL) Insiders Been Selling Their Stock?Have Charles River Laboratories International, Inc. (NYSE:CRL) Insiders Been Selling Their Stock?
nasdaq.com - November 5 at 7:29 AM
Results: Charles River Laboratories International, Inc. Beat Earnings Expectations And Analysts Now Have New ForecastsResults: Charles River Laboratories International, Inc. Beat Earnings Expectations And Analysts Now Have New Forecasts
nasdaq.com - November 1 at 9:19 AM
Earnings Beat: Charles River Laboratories International, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their ModelsEarnings Beat: Charles River Laboratories International, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
finance.yahoo.com - November 1 at 9:19 AM
Charles River Laboratories International (CRL) CEO James Foster on Q3 2020 Results - Earnings Call TranscriptCharles River Laboratories International (CRL) CEO James Foster on Q3 2020 Results - Earnings Call Transcript
seekingalpha.com - October 31 at 7:18 AM
DateCompanyBrokerageAction
5/4/2021Siemens HealthineersJPMorgan Chase & Co.Reiterated Rating
5/4/2021Siemens HealthineersCredit Suisse GroupReiterated Rating
5/4/2021Siemens HealthineersDeutsche Bank AktiengesellschaftUpgrade
4/30/2021Siemens HealthineersBarclaysReiterated Rating
4/29/2021Siemens HealthineersBerenberg BankReiterated Rating
3/16/2021Siemens HealthineersHSBCUpgrade
2/23/2021Siemens HealthineersUBS GroupReiterated Rating
1/6/2021Siemens HealthineersStifel NicolausUpgrade
12/9/2020Siemens HealthineersMorgan StanleyUpgrade
12/9/2020Siemens HealthineersAlphaValueUpgrade
12/3/2020Siemens HealthineersCommerzbankUpgrade
12/3/2020Siemens HealthineersBank of AmericaUpgrade
10/26/2020Siemens HealthineersRoyal Bank of CanadaReiterated Rating
(Data available from 5/5/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.